Insuficiencia renal aguda en tiempos de COVID-19: pautas para su atención.
Open Access
- 1 January 2026
- journal article
- Published by Universidad Metropolitana in Revista Metropolitana de Ciencias Aplicadas
- Vol. 9 (1) , 190-200
Abstract
The COVID-19 disease represents a global challenge with significant impacts on public health. Beyond its primary respiratory manifestations, evidence has shown its potential to damage multiple organs, including the kidneys, which can lead to acute kidney injury. The pathogenesis of this renal involvement in infected patients encompasses direct pathways. The purpose of this research was to establish a procedure for identifying the most effective therapies to manage kidney injury in individuals with COVID-19. An observational study was conducted, supplemented by a literature review in platforms such as Google Scholar, SciELO, and PubMed, following the PRISMA methodology. A retrospective comparative analysis was performed between patients with general acute kidney injury (AKI) and those with AKI induced by COVID-19. The results highlight the importance of a holistic approach that incorporates fluid rehydration, adjusted administration of diuretics, inflammation management with corticosteroids, anticoagulant prophylaxis, and selective antibiotics. Patients with COVID-19-associated AKI exhibit a higher number of comorbidities and longer stays in the intensive care unit (ICU) compared to those with general AKI. In critical scenarios, renal replacement therapy is recommended to improve survival rates and prevent progression to chronic kidney disease. Managing acute kidney injury in the context of COVID-19 requires a personalized strategy supported by scientific evidence. Early detection and the implementation of a robust therapeutic protocol can optimize clinical outcomes and reduce mortality associated with this complication.Keywords
This publication has 13 references indexed in Scilit:
- Exploring adolescent suicide attempts before and during the coronavirus disease 2019 pandemic: a cross-sectional studyRevista Paulista de Pediatria, 2025
- Tocilizumab in COVID-19: A Double-Edged Sword?Biomedicines, 2024
- Fenoldopam for preventing and treating acute kidney injuryCochrane Database of Systematic Reviews, 2024
- Risk factors and outcome of acute kidney injury in critically ill patients with SARS-CoV-2 pneumonia: a multicenter studyMedicina Intensiva (English Edition), 2024
- Tratamiento con heparinasEMC - Tratado de Medicina, 2024
- Estrategias de prevención y tratamiento de la infección por SARS-CoV-2 (Severe Acute Respiratory Coronavirus 2) en pacientes con enfermedad renal crónica: revisión de la literaturaNefrología, 2023
- COVID 19 y enfermedad renal crónicaGaceta Médica de México, 2022
- Insuficiencia renal y hemodiálisis en pacientes hospitalizados con COVID-19 durante la primera ola en Lima, PerúACTA MEDICA PERUANA, 2022
- Lesión renal aguda en COVID-19: puesta al día y revisión de la literaturaActa Colombiana de Cuidado Intensivo, 2022
- Fracaso renal agudo en pacientes hospitalizados por COVID-19Nefrología, 2021